Pei yin Lin

Summary

Publications

  1. ncbi request reprint Targeting the PI3K-Akt pathway in kidney cancer
    Jin Young Park
    Division of Nephrology, Department of Internal Medicine, Immunology Graduate Group, University of California, Davis, CA 95616, USA
    Expert Rev Anticancer Ther 7:863-70. 2007
  2. pmc Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance
    Pei yin Lin
    Division of Nephrology, Department of Internal Medicine, University of California, Davis, CA, USA
    Mol Cancer 6:16. 2007
  3. pmc Pathway analysis of kidney cancer using proteomics and metabolic profiling
    Bertrand Perroud
    Genome Center, University of California, Davis, CA, USA
    Mol Cancer 5:64. 2006
  4. ncbi request reprint p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches
    Robert H Weiss
    Division of Nephrology, Department of Internal Medicine, University of California, Davis, California 95616, USA
    J Urol 177:63-8; discussion 68-9. 2007

Detail Information

Publications4

  1. ncbi request reprint Targeting the PI3K-Akt pathway in kidney cancer
    Jin Young Park
    Division of Nephrology, Department of Internal Medicine, Immunology Graduate Group, University of California, Davis, CA 95616, USA
    Expert Rev Anticancer Ther 7:863-70. 2007
    ..In this review, we discuss PI3K-Akt inhibitors as well as inhibitors of pathways and targets both immediately up- and downstream of this cascade, many of which show promise in the clinic...
  2. pmc Attenuation of PTEN increases p21 stability and cytosolic localization in kidney cancer cells: a potential mechanism of apoptosis resistance
    Pei yin Lin
    Division of Nephrology, Department of Internal Medicine, University of California, Davis, CA, USA
    Mol Cancer 6:16. 2007
    ..Renal cell carcinoma (RCC) is associated with frequent treatment failures (approximately 90% in metastatic cases), and these tumors frequently contain PTEN abnormalities...
  3. pmc Pathway analysis of kidney cancer using proteomics and metabolic profiling
    Bertrand Perroud
    Genome Center, University of California, Davis, CA, USA
    Mol Cancer 5:64. 2006
    ....
  4. ncbi request reprint p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches
    Robert H Weiss
    Division of Nephrology, Department of Internal Medicine, University of California, Davis, California 95616, USA
    J Urol 177:63-8; discussion 68-9. 2007
    ..The apoptosis and cell cycle regulatory protein, p21(waf1/cip1), has been investigated as a possible target in other cancers since it is involved in the repair and apoptotic response of normal and malignant cells to DNA damage...